Intrafamilial Phenotypical Variability Linked to PRKAG2 Mutation—Family Case Report and Review of the Literature
Abstract
:1. Background
2. Case Presentation
3. Discussions
4. Conclusions
5. Learning Points
- PRKAG2 syndrome represents one of the HCM genocopies and highlights the need for a high index of suspicion for these conditions in the assessment of cardiac hypertrophy.
- The presence of unexplained HCM associated with WPW syndrome and/or conduction system degeneration should lead to the suspicion of PRKAG2 syndrome.
- Genotyping can be a powerful tool for identifying patients with storage phenocopies such as PRKAG2, which can be confirmed only with genetic testing by an identification of a PRKAG2 mutation.
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Murphy, R.T.; Mogensen, J.; McGarry, K.; Bahl, A.; Evans, A.; Osman, E.; Syrris, P.; Gorman, G.; Farrell, M.; Holton, J.L.; et al. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: Natural history. J. Am. Coll. Cardiol. 2005, 45, 922–930. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Scott, J.W.; Hawley, S.A.; Green, K.A.; Anis, M.; Stewart, G.; Scullion, G.A.; Norman, D.G.; Hardie, D.G. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Investig. 2004, 113, 274–284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cheung, P.C.; Salt, I.P.; Davies, S.P.; Hardie, D.G.; Carling, D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 2000, 346, 659–669. [Google Scholar] [CrossRef] [PubMed]
- Arad, M.; Benson, D.W.; Perez-Atayde, A.R.; McKenna, W.J.; Sparks, E.A.; Kanter, R.J.; McGarry, K.; Seidman, J.; Seidman, C.E. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J. Clin. Investig. 2002, 109, 357–362. [Google Scholar] [CrossRef]
- Gruner, C.; Care, M.; Siminovitch, K.; Moravsky, G.; Wigle, E.D.; Woo, A.; Rakowski, H. Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. Circ. Cardiovasc. Genet. 2011, 4, 288–295. [Google Scholar] [CrossRef] [Green Version]
- Gollob, M.H.; Green, M.S.; Tang, A.S.-L.; Gollob, T.; Karibe, A.; Hassan, A.-S.; Ahmad, F.; Lozado, R.; Shah, G.; Fananapazir, L.; et al. Identification of a Gene Responsible for Familial Wolff–Parkinson–White Syndrome. N. Engl. J. Med. 2001, 344, 1823–1831. [Google Scholar] [CrossRef]
- Arad, M.; Maron, B.J.; Gorham, J.M.; Johnson, W.H., Jr.; Saul, J.P.; Perez-Atayde, A.R.; Spirito, P.; Wright, G.B.; Kanter, R.J.; Seidman, C.E.; et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 2005, 352, 362–372. [Google Scholar] [CrossRef] [Green Version]
- Gollob, M.; Seger, J.J.; Gollob, T.N.; Tapscott, T.; Gonzales, O.; Bachinski, L.; Roberts, R. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular Preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 2001, 104, 3030–3033. [Google Scholar] [CrossRef] [Green Version]
- Sidhu, J.R.R. Genetic basis and pathogenesis of Familial WPW Syndrome. Indian Pacing Electrophysiol. J. 2003, 3, 197–201. [Google Scholar]
- Miyamoto, L. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome. J. Med. Investig. 2018, 65, 1–8. [Google Scholar] [CrossRef] [Green Version]
- Porto, A.G.; Brun, F.; Severini, G.M.; Losurdo, P.; Fabris, E.; Taylor, M.R.; Mestroni, L.; Sinagra, G. Clinical Spectrum of PRKAG2 Syndrome. Circ. Arrhythmia Electrophysiol. 2016, 9, e003121. [Google Scholar] [CrossRef] [PubMed]
- Kim, M.; Hunter, R.W.; Garcia-Menendez, L.; Gong, G.; Yang, Y.-Y.; Kolwicz, S.C., Jr.; Xu, J.; Sakamoto, K.; Wang, W.; Tian, R. Mutation in the γ2-Subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage. Circ. Res. 2014, 114, 966–975. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Oliveira, S.M.; Zhang, Y.-H.; Solis, R.S.; Isackson, H.; Bellahcene, M.; Yavari, A.; Pinter, K.; Davies, J.K.; Ge, Y.; Ashrafian, H.; et al. AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes. Circ. Res. 2012, 110, 1192–1201. [Google Scholar] [CrossRef] [Green Version]
- Liu, Y.; Bai, R.; Wang, L.; Zhang, C.; Zhao, R.; Wan, D.; Chen, X.; Caceres, G.; Barr, D.; Barajas-Martinez, H.; et al. Identification of a Novel De Novo Mutation Associated with PRKAG2 Cardiac Syndrome and Early Onset of Heart Failure. PLoS ONE 2013, 8, e64603. [Google Scholar] [CrossRef] [PubMed]
- Roberts, J.D.; Veinot, J.P.; Rutberg, J.; Gollob, M.H. Inherited cardiomyopathies mimicking arrhythmogenic right ventricular cardiomyo-pathy. Cardiovasc. Pathol. 2010, 19, 316–320. [Google Scholar] [CrossRef] [PubMed]
- Lopez-Sainz, A.; Dominguez, F.; Lopes, L.R.; Ochoa, J.P.; Barriales-Villa, R.; Climent, V.; Linschoten, M.; Tiron, C.; Chiriatti, C.; Marques, N.; et al. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis. J. Am. Coll. Cardiol. 2020, 76, 186–197. [Google Scholar] [CrossRef]
- Chen, S.; Lin, Y.; Zhu, Y.; Geng, L.; Cui, C.; Li, Z.; Liu, H.; Chen, H.; Ju, W.; Chen, M. Atrial Lesions in a Pedigree With PRKAG2 Cardiomyopathy: Involvement of Disrupted AMP-Activated Protein Kinase Signaling. Front. Cardiovasc. Med. 2022, 9, 840337. [Google Scholar] [CrossRef]
- Yuan, W.-Z.; Shang, L.; Tian, D.-S.; Wu, S.-W.; You, Y.; Tian, C.-L.; Wu, B.; Liu, J.; Sun, Q.-J.; Liu, Q.; et al. Monogenic basis of young-onset cryptogenic stroke: A multicenter study. Ann. Transl. Med. 2022, 10, 512. [Google Scholar] [CrossRef]
- Ahamed, H.; Balegadde, A.V.; Menon, S.; Menon, R.; Ramachandran, A.; Mathew, N.; Natarajan, K.U.; Nair, I.R.; Kannan, R.; Shankar, M.; et al. Phenotypic expression and clinical out-comes in a South Asian PRKAG2 cardiomyopathy cohort. Sci. Rep. 2020, 10, 20610. [Google Scholar] [CrossRef]
- Pena, J.L.B.; Santos, W.C.; Siqueira, M.H.A.; Sampaio, I.H.; Moura, I.C.G.; Sternick, E.B. Glycogen storage cardiomyopathy (PRKAG2): Diagnostic findings of standard and advanced echocardiography techniques. Eur. Heart J. Cardiovasc. Imaging 2020, 22, 800–807. [Google Scholar] [CrossRef]
- Yogasundaram, H.; Paterson, I.D.; Graham, M.; Sergi, C.; Oudit, G.Y. Glycogen Storage Disease Because of a PRKAG2 Mutation Causing Severe Biventricular Hypertrophy and High-Grade Atrio-Ventricular Block. Circ. Heart Fail. 2016, 9, e003367. [Google Scholar] [CrossRef] [PubMed]
- Pöyhönen, P.; Hiippala, A.; Ollila, L.; Kaasalainen, T.; Hänninen, H.; Heliö, T.; Tallila, J.; Vasilescu, C.; Kivistö, S.; Ojala, T.; et al. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations. J. Cardiovasc. Magn. Reson. 2015, 17, 89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sternick, E.B.; de Almeida Araujo, S.; Rocha, C.; Gollob, M. Myocardial infarction in a teenager. Eur. Heart J. 2014, 35, 1558. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fabris, E.; Brun, F.; Porto, A.G.; Losurdo, P.; Vitali Serdoz, L.; Zecchin, M.; Severini, G.M.; Mestroni, L.; Di Chiara, A.; Sinagra, G. Cardiac hypertrophy, accessory pathway, and con-duction system disease in an adolescent: The PRKAG2 cardiac syndrome. J. Am. Coll. Cardiol. 2013, 62, e17. [Google Scholar] [CrossRef] [Green Version]
- Hu, D.; Hu, D.; Liu, L.; Barr, D.; Liu, Y.; Balderrabano-Saucedo, N.; Wang, B.; Zhu, F.; Xue, Y.; Wu, S.; et al. Identification, clinical manifestation and structural mech-anisms of mutations in AMPK associated cardiac glycogen storage disease. eBioMedicine 2020, 54, 102723. [Google Scholar] [CrossRef]
- Burwinkel, B.; Scott, J.W.; Bührer, C.; Van Landeghem, F.K.; Cox, G.F.; Wilson, C.J.; Hardie, D.G.; Kilimann, M.W. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphor-ylase kinase deficiency. Am. J. Hum. Genet. 2005, 76, 1034–1049. [Google Scholar] [CrossRef]
- Sternick, E.B.; Oliva, A.; Gerken, L.M.; Magalhaes, L.; Scarpelli, R.; Correia, F.S.; Rego, S.; Santana, O.; Brugada, R.; Wellens, H.J. Clinical, electrocardiographic, and electrophysi-ologic characteristics of patients with a fasciculoventricular pathway: The role of PRKAG2 mutation. Heart Rhythm. 2011, 8, 58–64. [Google Scholar] [CrossRef]
- Laforêt, P.; Richard, P.; Said, M.A.; Romero, N.B.; Lacene, E.; Leroy, J.-P.; Baussan, C.; Hogrel, J.-Y.; Lavergne, T.; Wahbi, K.; et al. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis. Neuromuscul. Disord. 2006, 16, 178–182. [Google Scholar] [CrossRef]
- Authors, M. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Car-diomyopathy of the European Society of Cardiology (ESC). Eur. Heart J. 2014, 35, 2733–2779. [Google Scholar]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Marcu, A.S.; Vătăşescu, R.; Onciul, S.; Rădoi, V.; Jurcuţ, R. Intrafamilial Phenotypical Variability Linked to PRKAG2 Mutation—Family Case Report and Review of the Literature. Life 2022, 12, 2136. https://doi.org/10.3390/life12122136
Marcu AS, Vătăşescu R, Onciul S, Rădoi V, Jurcuţ R. Intrafamilial Phenotypical Variability Linked to PRKAG2 Mutation—Family Case Report and Review of the Literature. Life. 2022; 12(12):2136. https://doi.org/10.3390/life12122136
Chicago/Turabian StyleMarcu, Andreea Sorina, Radu Vătăşescu, Sebastian Onciul, Viorica Rădoi, and Ruxandra Jurcuţ. 2022. "Intrafamilial Phenotypical Variability Linked to PRKAG2 Mutation—Family Case Report and Review of the Literature" Life 12, no. 12: 2136. https://doi.org/10.3390/life12122136